101
|
β-Conglycinin (7S) and glycinin (11S) exert a hypocholesterolemic effect comparable to that of fenofibrate in rats fed a high-cholesterol diet. J Funct Foods 2010. [DOI: 10.1016/j.jff.2010.11.001] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
|
102
|
Klein MA, Nahin RL, Messina MJ, Rader JI, Thompson LU, Badger TM, Dwyer JT, Kim YS, Pontzer CH, Starke-Reed PE, Weaver CM. Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J Nutr 2010; 140:1192S-1204S. [PMID: 20392880 PMCID: PMC2869505 DOI: 10.3945/jn.110.121830] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
The NIH sponsored a scientific workshop, "Soy Protein/Isoflavone Research: Challenges in Designing and Evaluating Intervention Studies," July 28-29, 2009. The workshop goal was to provide guidance for the next generation of soy protein/isoflavone human research. Session topics included population exposure to soy; the variability of the human response to soy; product composition; methods, tools, and resources available to estimate exposure and protocol adherence; and analytical methods to assess soy in foods and supplements and analytes in biologic fluids and other tissues. The intent of the workshop was to address the quality of soy studies, not the efficacy or safety of soy. Prior NIH workshops and an evidence-based review questioned the quality of data from human soy studies. If clinical studies are pursued, investigators need to ensure that the experimental designs are optimal and the studies properly executed. The workshop participants identified methodological issues that may confound study results and interpretation. Scientifically sound and useful options for dealing with these issues were discussed. The resulting guidance is presented in this document with a brief rationale. The guidance is specific to soy clinical research and does not address nonsoy-related factors that should also be considered in designing and reporting clinical studies. This guidance may be used by investigators, journal editors, study sponsors, and protocol reviewers for a variety of purposes, including designing and implementing trials, reporting results, and interpreting published epidemiological and clinical studies.
Collapse
Affiliation(s)
- Marguerite A. Klein
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907,To whom correspondence should be addressed. E-mail:
| | - Richard L. Nahin
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Mark J. Messina
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Jeanne I. Rader
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Lilian U. Thompson
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Thomas M. Badger
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Johanna T. Dwyer
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Young S. Kim
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Carol H. Pontzer
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Pamela E. Starke-Reed
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| | - Connie M. Weaver
- Office of Dietary Supplements,; National Center for Complementary and Alternative Medicine,; National Cancer Institute, and Division of Nutrition Research Coordination, National Institutes of Health, Bethesda, MD 20892; Department of Nutrition, Loma Linda University, Loma Linda, CA 92350; Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, MD 20740; Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2; Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72202; Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907
| |
Collapse
|
103
|
Honda K, Kamisoyama H, Tominaga Y, Yokota S, Hasegawa S. The molecular mechanism underlying the reduction in abdominal fat accumulation by licorice flavonoid oil in high fat diet-induced obese rats. Anim Sci J 2010; 80:562-9. [PMID: 20163621 DOI: 10.1111/j.1740-0929.2009.00670.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Licorice (Glycyrrhiza glabra) has been widely used in traditional medicines, and its flavonoid oil (LFO) decreases abdominal adipose tissue weight in mammals. In the present study, we investigated the molecular mechanisms underlying the decrease in abdominal adipose tissue weight by LFO. LFO significantly decreased the mRNA levels of rate-limiting enzymes in the hepatic fatty acid synthetic pathway, whereas LFO significantly increased the mRNA levels of a rate-limiting enzyme in the hepatic fatty acid oxidative pathway. LFO significantly decreased the mRNA levels of sterol regulatory element-binding protein-1c (SREBP-1c) (a transcription factor that promotes hepatic fatty acid synthesis), whereas the mRNA levels of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) (a transcription factor that promotes hepatic fatty acid oxidation) was significantly increased. All our findings suggest that the decrease in abdominal adipose tissue weight by LFO is mediated by the transcriptional regulation of SREBP-1c and PPAR-alpha in the liver. Thus, we infer that the natural ingredient LFO is a promising candidate for use as a feed additive to reduce abdominal fat accumulation in domestic animals.
Collapse
Affiliation(s)
- Kazuhisa Honda
- Department of Bioresource Science, Graduate School of Agricultural Science, Kobe University, Nada, Kobe, Japan
| | | | | | | | | |
Collapse
|
104
|
Nagano M, Ueno T, Fujii A, Hou DX, Fujii M. Anti-Hyperglycemic Effect of Kurozu Moromi Powder in Type II Diabetic Model KK-A y Mice. J JPN SOC FOOD SCI 2010. [DOI: 10.3136/nskkk.57.346] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
| | | | | | - De-Xing Hou
- Department of Biochemical Science and Technology, Faculty of Agriculture, Kagoshima University
| | - Makoto Fujii
- Department of Biochemical Science and Technology, Faculty of Agriculture, Kagoshima University
| |
Collapse
|
105
|
|
106
|
Simmen FA, Mercado CP, Zavacki AM, Huang SA, Greenway AD, Kang P, Bowman MT, Prior RL. Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat. J Nutr Biochem 2009; 21:1106-13. [PMID: 19962299 DOI: 10.1016/j.jnutbio.2009.09.008] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2009] [Revised: 09/16/2009] [Accepted: 09/21/2009] [Indexed: 12/13/2022]
Abstract
We hypothesized that consumption of soy protein isolate (SPI) or the soy isoflavone genistein (GEN) would modulate mRNA expression of genes underlying lipid and thyroid hormone metabolism in livers and small intestines of young adult male Sprague-Dawley rats. Early pregnant rat dams were placed on AIN-93G diets containing casein (CAS, control protein), SPI, or CAS+GEN. Litters were weaned to the same diet as their dam. SPI-fed (but not GEN-fed) male rats of 48 days of age had significant reductions in body weight, abdominal fat pad weight and hepatic content of lipid droplets and triglycerides. Hepatic peroxisome proliferator-activated receptor α (Ppara) transcripts were elevated with SPI but not GEN diet. Hepatic pyruvate dehydrogenase kinase-4 (Pdk4) and cytochrome P450 4A10 (Cyp4a10) mRNA abundance was reduced with SPI; the SPI effect on Cyp4a10 was recapitulated by GEN diet. SPI (but not GEN) suppressed Pdk4 and 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2) mRNA abundance in duodenum. Liver iodothyronine deiodinase types 1 and 2 (Dio1 and Dio2) mRNA levels were increased with SPI diet; the effect on Dio2, but not Dio1 mRNAs, also was observed with GEN. SPI and GEN increased hepatic types 1 and 2 iodothyronine deiodinase (D1 and D2) activities. Effects of SPI and GEN on the above gene expression may contribute to the observed reductions in body and adipose tissue weight and liver lipid content in this model. Identification of the regulation, by genistein and soy protein, of iodothyronine deiodinase synthesis has potential applications for treatment and prevention of fatty liver disease and obesity.
Collapse
Affiliation(s)
- Frank A Simmen
- Arkansas Children's Nutrition Center, Little Rock, AR 72202, USA.
| | | | | | | | | | | | | | | |
Collapse
|
107
|
Hayashi M, Kitamura K, Harada K. Genetic mapping of Cgdef gene controlling accumulation of 7S globulin (beta-conglycinin) subunits in soybean seeds. J Hered 2009; 100:802-6. [PMID: 19605467 DOI: 10.1093/jhered/esp046] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Soy protein consists of mainly 7S globulin (beta-conglycinin) and 11S globulin (glycinin). The 7S globulin exerts favorable and unfavorable effects on human nutrition, food processing, and human health. Therefore, it is important for the improvement of the soy protein to control the content of 7S globulin. A mutant line lacking the 7S globulin was induced by gamma-ray irradiation, and the deficiency is controlled by a single recessive gene, cgdef. The Cgdef gene, despite its potential for improvement of the soy protein, has not been assigned to a linkage group of a soybean genetic map. We crossed "Mo-shi-dou Gong 503" with plants homozygous or heterozygous for the Cgdef allele and screened an F2 mapping population that segregated with the cgdef allele to locate the Cgdef gene on a soybean genetic map. By linkage analysis, we assigned the Cgdef gene to chromosome 19 at the position between the Satt523 and Sat_388 simple sequence repeat (SSR) markers. Six SSR markers (Sat_134, Sat_405, Satt143, Satt398, Sat_195, and Satt694) and 2 amplified fragment length polymorphism markers identified previously were mapped at the same position of the Cgdef gene. These markers should enable to conduct map-based cloning of the Cgdef gene.
Collapse
Affiliation(s)
- Masaki Hayashi
- National Institute of Agrobiological Sciences, Tsukuba, Ibaraki, Japan.
| | | | | |
Collapse
|
108
|
Kim J, Park J, Hong S, Kim MK. Effect of corn gluten and its hydrolysate consumptions on weight reduction in rats fed a high-fat diet. Nutr Res Pract 2009; 3:200-7. [PMID: 20090885 PMCID: PMC2808719 DOI: 10.4162/nrp.2009.3.3.200] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2008] [Revised: 03/31/2009] [Accepted: 04/26/2009] [Indexed: 11/04/2022] Open
Abstract
This study examined the effects of corn gluten (CG) and its hydrolysate consumptions on weight reduction in rats fed a high-fat diet. Eight-month-old male Sprague-Dawley rats (n=40) were fed a high-fat diet (40% calorie as fat) for 4 weeks. They were then randomly divided into four groups and fed the isocaloric diets with different protein sources for 8 weeks. The protein sources were casein (control group), intact CG (CG group), CG hydrolysate A (CGHA group, 30% of protein as peptides and 70% as free amino acids) and CG hydrolysate P (CGHP group, 93% of protein as peptides and 7% as free amino acids). Body weight gain, adipose tissue weights, nitrogen balance, absorptions of energy, protein and fat, lipid profiles in plasma, liver and feces and hepatic activities of carnitine palmitoyl transferase (CPT), fatty acid synthase (FAS), malic enzyme (ME) and glucose-6-phosphate dehydrogenase (G6PDH) were assessed. The CGHA diet had the highest amount of BCAAs, especially leucine, and most of them existed as free amino acid forms. The CGHA group showed significant weight reduction and negative nitrogen balance. Protein absorption and apparent protein digestibility in the CGHA group were significantly lower than those in other groups. Adipose tissue weights were the lowest in the CGHA group. Activity of CPT tended to be higher in the CGHA group than in other groups and those of FAS, ME and G6PDH were significantly lower in the CGHA group than in other groups. In conclusion, the CGHA diet which had relatively high amounts of free amino acids and BCAAs, especially leucine, had a weight reduction effect by lowering adipose tissue weight and the activities of FAS, ME and G6PDH in experimental animals, but it seemed to be a negative result induced by lowering protein absorption, increasing urinary nitrogen excretion and protein catabolism.
Collapse
Affiliation(s)
- Joohee Kim
- Department of Food & Nutritional Sciences, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea
| | | | | | | |
Collapse
|
109
|
Martinez-Villaluenga C, Dia VP, Berhow M, Bringe NA, Gonzalez de Mejia E. Protein hydrolysates from beta-conglycinin enriched soybean genotypes inhibit lipid accumulation and inflammation in vitro. Mol Nutr Food Res 2009; 53:1007-18. [PMID: 19603404 DOI: 10.1002/mnfr.200800473] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Obesity is a worldwide health concern and a well recognized predictor of premature mortality associated with a state of chronic inflammation. The objective was to evaluate the effect of soy protein hydrolysates (SPH) produced from different soybean genotypes by alcalase (SAH) or simulated gastrointestinal digestion (SGIH) on lipid accumulation in 3T3-L1 adipocytes. The anti-inflammatory effect of SPH produced by alcalase on LPS-induced macrophage RAW 264.7 cell line was also investigated. SAH (100 microM) derived from soybean enriched in beta-conglycinin (BC) (up to 47% total protein) decreased lipid accumulation (33-37% inhibition) through downregulation of gene expression of lipoprotein lipase (LPL) and fatty acid synthase (FAS). SGIH (100 microM) inhibited lipid accumulation to a lesser extent (8-14% inhibition) through inhibition of LPL gene expression. SAH (5 microM) decreased the production of nitric oxide (NO) (18-35%) and prostaglandin E(2) (PGE(2)) (47-71%) and the expression of inducible nitric oxide synthase (iNOS) (31-53%) and cycloxygenase-2 (COX-2) (30-52%). This is the first investigation showing that soy hydrolysates inhibit LPS-induced iNOS/NO and COX-2/PGE(2 )pathways in macrophages. Soybeans enriched in BCs can provide hydrolysates that limit fat accumulation in fat cells and inflammatory pathways in vitro and therefore warrant further studies as a healthful food.
Collapse
|
110
|
Abstract
Reviewed here are the modes of action of soy components used as ingredients in foods, which can lower plasma levels of low-density lipoprotein (LDL) and cholesterol, which are markers for the risk for atherosclerosis. Soy ingredients act via more than one mode of action including the following: LDL absorption suppression, cholesterol efflux stimulation, LDL resorption stimulation, LDL oxidation prevention, LDL particle size increase, cholesterol synthesis reduction, and bile secretion increase. Individual genetics, lifestyle, and nutrition habits alter LDL management and a better understanding of the various modes of actions of soy ingredients may facilitate the composition of effective ingredient cocktails. The optimization of food components offers further alternatives to LDL management to augment drug therapy for patients who are unable to reach their target LDL cholesterol levels or who are suffering from side effects or drug insensitivity.
Collapse
Affiliation(s)
- Jan H van Ee
- Archer Daniels Midland Company, Koog aan de Zaan, The Netherlands.
| |
Collapse
|
111
|
Egusa S, Otani H. Soybean protein fraction digested with neutral protease preparation, "Peptidase R", produced by Rhizopus oryzae, stimulates innate cellular immune system in mouse. Int Immunopharmacol 2009; 9:931-6. [PMID: 19348966 DOI: 10.1016/j.intimp.2009.03.020] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2008] [Revised: 03/10/2009] [Accepted: 03/27/2009] [Indexed: 11/23/2022]
Abstract
A soybean protein fraction was prepared from defatted soybean seed flour and digested with 29 kinds of commercially available protease originating from preparations of animals, plants, and microorganisms. Some digests, in particular, Ro-digest prepared using a Rhizopus oryzae neutral protease preparation (Peptidase R), displayed strong mitogenic activity toward C3H/HeN mouse spleen cells. The number of spleen CD11b+, CD49b+, interleukin (IL)-12+CD11b+, and interferon (IFN)-gamma+CD49b+ cells significantly increased when cultured with Ro-digest. Similarly, the number of spleen IFN-gamma+CD4+ cells significantly increased in the presence of Ro-digest while that of spleen IL-4+CD4+ cells was largely unchanged. Additionally, 5-week-old male C3H/HeN mice were given diets consisting of ovalbumin (OVA) alone (control diet) or a mixture of OVA and Ro-digest (Ro-digest-added diet) as a protein source for 5 weeks, and the immune properties of the mice were investigated. The number of IL-12+CD11b+ cells was greater in spleens from mice given the Ro-digest-added diet than in those given the control diet. The cytotoxic activity of spleen cells toward the human erythroleukemia cell line, K562, was significantly higher in mice given the Ro-digest-added diet than in those given the control diet. Furthermore, in a microarray analysis of mRNAs extracted from mice Peyer's patch cells, gene expression related to innate immune responses was increased in mice given the Ro-digest-added diet. These results indicate that the Ro-digest might stimulate cellular immune systems, in particular, an innate immunity in mice.
Collapse
MESH Headings
- Animals
- Antigens, CD/genetics
- Antigens, CD/metabolism
- Aspartic Acid Endopeptidases/chemistry
- Aspartic Acid Endopeptidases/metabolism
- Cytotoxicity, Immunologic
- Feeding Behavior
- Gene Expression Regulation
- Humans
- Immunity, Innate
- Immunologic Factors/chemistry
- Immunologic Factors/immunology
- Immunologic Factors/metabolism
- Interferon-gamma/genetics
- Interferon-gamma/metabolism
- Interleukin-12/genetics
- Interleukin-12/metabolism
- Interleukin-4/genetics
- Interleukin-4/metabolism
- K562 Cells
- Leukemia, Erythroblastic, Acute/immunology
- Leukemia, Erythroblastic, Acute/metabolism
- Leukemia, Erythroblastic, Acute/pathology
- Male
- Mice
- Mice, Inbred C3H
- Oligonucleotide Array Sequence Analysis
- Peyer's Patches/immunology
- Peyer's Patches/metabolism
- Peyer's Patches/pathology
- Plant Proteins, Dietary/chemistry
- Plant Proteins, Dietary/immunology
- Plant Proteins, Dietary/metabolism
- Rhizopus/enzymology
- Glycine max
- Spleen/immunology
- Spleen/metabolism
- Spleen/pathology
Collapse
Affiliation(s)
- Shintaro Egusa
- Interdisciplinary Graduate School of Science & Technology, Shinshu University, Minamiminowa-mura 8304, Kamiina-gun, Nagano 399-4598, Japan
| | | |
Collapse
|
112
|
Asaoka K, Yasukawa K, Inouye K. Coagulation of soy proteins induced by thermolysin and comparison of the coagulation reaction with that induced by subtilisin Carlsberg. Enzyme Microb Technol 2009. [DOI: 10.1016/j.enzmictec.2008.10.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
113
|
Alimentary proteins, amino acids and cholesterolemia. Amino Acids 2009; 38:15-22. [DOI: 10.1007/s00726-009-0239-6] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2009] [Accepted: 01/12/2009] [Indexed: 11/26/2022]
|
114
|
Inouye K, Nakano M, Asaoka K, Yasukawa K. Effects of thermal treatment on the coagulation of soy proteins induced by subtilisin Carlsberg. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2009; 57:717-723. [PMID: 19117398 DOI: 10.1021/jf802693f] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The effects of thermal treatment on the subtilisin Carlsberg-induced coagulations of soy protein isolate (SPI) and soy proteins in 7S and 11S fractions, most of which are beta-conglycinin and glycinin, respectively, were examined by measuring the turbidity (OD(660)) of the reaction solutions. With the treatment at 37-60 degrees C, the turbidity did not increase at all by the proteolysis, while with the treatment at 70-96 degrees C, it drastically increased. The degree of the coagulation is the highest for the treatment at 80 degrees C and the most remarkable for 11S soy protein. Changes in the sodium dodecyl sulfate-polyacrylamide gel electrophoresis pattern of the digests during the proteolysis were in good agreement with those in the turbidities for SPI and 7S and 11S soy proteins. Circular dichroism analysis revealed that the amounts of nonstructured protein in SPI and 7S and 11S soy proteins were initially 40-50%, increased to 55-60% by the treatment at 80 degrees C, and further increased to 65-75% by the proteolysis. The maximum fluorescence intensity of SPI and 7S and 11S soy proteins increased with an increase in the incubation temperature up to 80 degrees C. These findings suggest that the thermal treatment at 80 degrees C most effectively changes the secondary structure of soy proteins and renders them coagulate when hydrolyzed by subtilisin Carlsberg.
Collapse
Affiliation(s)
- Kuniyo Inouye
- Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Japan.
| | | | | | | |
Collapse
|
115
|
Martinez-Villaluenga C, Bringe NA, Berhow MA, Gonzalez de Mejia E. Beta-conglycinin embeds active peptides that inhibit lipid accumulation in 3T3-L1 adipocytes in vitro. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2008; 56:10533-43. [PMID: 18947234 DOI: 10.1021/jf802216b] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Obesity is a worldwide health concern because it is a well-recognized predictor of premature mortality. The objective was to identify soybean varieties that have improved potential to inhibit fat accumulation in adipocytes by testing the effects of soy hydrolysates having a range of protein subunit compositions on lipid accumulation and adiponectin expression in 3T3-L1 adipocytes. The results showed that differences in the protein distribution of 15 soy genotypes led to different potentials for the reduction of fat accumulation. The inhibition of lipid accumulation of soy alcalase hydrolysates in 3T3-L1 adipocytes ranged from 29 to 46%. Soy hydrolysates made from genotypes with 45.3 +/- 3.3% of total protein as beta-conglycinin, on average, showed significantly higher inhibition of lipid accumulation compared to those with 24.7 +/- 1.5% of extracted total protein as beta-conglycinin. Moreover, after in vitro simulated digestion with pepsin-pancreatin of the soy alcalase hydrolysates, 86% of the original activity remained. Adiponectin expression was induced in 3T3-L1 adipocytes treated with 15 soy hydrolysates up to 2.49- and 2.63-fold for high and low molecular weight adiponectin, respectively. The inhibition of lipid accumulation calculated from a partial least squares (PLS) analysis model correlated well with experimental data (R(2) = 0.91). In conclusion, it was feasible to differentiate soy varieties on the basis of the potential of their proteins to reduce fat accumulation using a statistical model and a cell-based assay in vitro. Furthermore, beta-conglycinin embeds more peptides than glycinin subunits that inhibit lipid accumulation and induce adiponectin in 3T3-L1 adipocytes. Therefore, soy ingredients containing beta-conglycinin may be important food components for the control of lipid accumulation in adipose tissue.
Collapse
|
116
|
The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 2008; 19:643-54. [DOI: 10.1016/j.jnutbio.2007.11.010] [Citation(s) in RCA: 487] [Impact Index Per Article: 30.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2007] [Accepted: 11/26/2007] [Indexed: 11/23/2022]
|
117
|
Abstract
Over the last decades, the prevalence of obesity and related diseases has increased rapidly in the Western world. Obesity is a disorder of energy balance and is associated with hyper-insulinemia, insulin resistance, and abnormalities in lipid metabolism, and it is one of the most important risk factors in the development of Type II diabetes, cardiovascular disease, atherosclerosis, and certain cancers. Because of the lower frequency of these diseases in Asian countries, attention has been turned toward the Asian diet, which consists highly of soy and soy-based products. The health benefits associated with soy consumption have been linked to the content of isoflavones, the main class of the phytoestrogens. As a result of their structural similarities to endogenous estrogens, isoflavones elicit weak estrogenic effects by competing with 17beta-estradiol (E2) for binding to the intranuclear estrogen receptors (ERs) and exert estrogenic or antiestrogenic effects in various tissues. The estrogenic activities of soy isoflavones are thought to play an important role in their health-enhancing properties. Additionally, the isoflavones have been proved to exert non-ER-mediated effects through numerous other pathways. Genistein, daidzein, and glycitein are the principal isoflavones in soy. Genistein is the most thoroughly examined of these, because it is the most prevalent isoflavone in soy and the most active of these compounds, because of its higher binding affinity for the ER. Genistein and daidzein can be obtained in high levels in humans under certain nutritional conditions, and epidemiologic and laboratory data suggest that these compounds could have health benefits in human obesity. This review will focus on the latest results of research on isoflavones and their effect on obesity in cell cultures, rodents, and humans.
Collapse
Affiliation(s)
- Anne Ørgaard
- Department of Veterinary Pathobiology, Faculty of Life Sciences, University of Copenhagen, Copenhagen, Denmark
| | | |
Collapse
|
118
|
Wagner JD, Zhang L, Shadoan MK, Kavanagh K, Chen H, Tresnasari K, Kaplan JR, Adams MR. Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys. Metabolism 2008; 57:S24-31. [PMID: 18555850 PMCID: PMC2570347 DOI: 10.1016/j.metabol.2008.04.001] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Isoflavones may influence insulin action by means of their well-known receptor-mediated estrogenic activity. However, isoflavones also bind to peroxisome proliferator-activated receptors (PPARs) that are strongly associated with insulin action. Soy protein with its isoflavones has previously been shown to improve glycemic control in diabetic postmenopausal women and to improve insulin sensitivity in ovariectomized monkeys. The purpose of the current report was to extend our studies of dietary soy protein to male monkeys and determine effects of the soy isoflavones on insulin resistance. Two studies are reported here. Study one involved 91 male monkeys consuming 3 diets differing only by the source of protein (casein-lactalbumin, soy protein with a low isoflavone concentration, or soy protein with a high isoflavone concentration). Intravenous glucose tolerance tests were done, and plasma adiponectin and lipoprotein concentrations were determined after 25 months of study. Samples of visceral fat were obtained at 31 months for assessment of adiponectin and PPARgamma expression. The second study involved 8 monkeys in a Latin-square design that compared the effects of diets with casein/lactalbumin, soy protein with a high isoflavone concentration, or soy protein that was alcohol-washed to deplete the isoflavones. After 8 weeks of treatment, insulin sensitivity and plasma lipoproteins were assessed. At 10 weeks, a biopsy of the skeletal muscle was performed for determination of insulin receptor, PPARalpha, and PPARgamma content. The major findings were that consumption of isoflavone-containing soy protein dose-dependently increased insulin responses to the glucose challenge and decreased plasma adiponectin, whereas isoflavone-depleted soy protein decreased body weight and had no effect on plasma adiponectin concentrations. Muscle PPARalpha and gamma expression was also increased with the isoflavone-depleted soy relative to either casein or soy protein containing the isoflavones. Further studies are needed to determine the mechanisms involved in these effects of a high-soy isoflavone diet and to optimize dietary isoflavone content for maximal health benefits in male subjects.
Collapse
Affiliation(s)
- Janice D Wagner
- Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1040, USA.
| | | | | | | | | | | | | | | |
Collapse
|
119
|
Bettzieche A, Brandsch C, Hirche F, Eder K, Stangl GI. L-cysteine down-regulates SREBP-1c-regulated lipogenic enzymes expression via glutathione in HepG2 cells. ANNALS OF NUTRITION AND METABOLISM 2008; 52:196-203. [PMID: 18544973 DOI: 10.1159/000138123] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/26/2007] [Accepted: 02/18/2008] [Indexed: 11/19/2022]
Abstract
BACKGROUND/AIM Protein-associated amino acids are supposed to play a role in sterol regulatory element-binding protein (SREBP)-mediated regulation of lipid metabolism. This study investigates the effects of cysteine on expression of SREBP-regulated hepatic genes. METHODS HepG2 cells which are an accepted model for the study of the lipid metabolism were treated with L-cysteine under different conditions. RESULTS Exposure of cells to L-cysteine reduced the mRNA concentrations of SREBP-1c (-35 to -43%) and its target genes fatty acid synthase (FAS; -20 to -50%), glucose-6-phosphate-dehydrogenase (G6PDH; -31 to -35%), and stearoyl-coenzyme A desaturase (SCD)1 (-34 to -50%). Cells treated with L-cysteine had 47% higher glutathione and 47% lower triglyceride concentrations than control cells. In cells which were concurrently treated with L-cysteine and L-buthionine-[S,R]-sulfoximine, an inhibitor of enzymatic glutathione synthesis, no down-regulation of the gene expression was observed. Pro-oxidant CuSO(4) up-regulated SREBP-1c (+71%), FAS (+165%), G6PDH (+84%) and SCD1 (+96%) mRNA abundance compared to control cells, but when cells were concurrently treated with L-cysteine, the gene expression remained at control level. CONCLUSIONS The results show that L-cysteine rapidly down-regulates the transcription of genes involved in fatty acid biosynthesis via a mechanism that appears to be mediated by an improved glutathione status.
Collapse
Affiliation(s)
- Anja Bettzieche
- Institute of Agricultural and Nutritional Sciences, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany
| | | | | | | | | |
Collapse
|
120
|
Abstract
Epidemiological investigations suggest that soy consumption may be associated with a lower incidence of certain chronic diseases. Clinical studies also show that ingestion of soy proteins reduces the risk factors for cardiovascular disease. This led to the approval of the food-labeling health claim for soy proteins in the prevention of coronary heart disease by the U.S. FDA in 1999. Similar health petitions for soy proteins have also been approved thereafter in the United Kingdom, Brazil, South Africa, the Philippines, Indonesia, Korea, and Malaysia. However, the purported health benefits are quite variable in different studies. The Nutrition Committee of the American Heart Association has assessed 22 randomized trials conducted since 1999 and found that isolated soy protein with isoflavones (ISF) slightly decreased LDL cholesterol but had no effect on HDL cholesterol, triglycerides, lipoprotein(a), or blood pressure. The other effects of soy consumption were not evident. Although the contributing factors to these discrepancies are not fully understood, the source of soybeans and processing procedures of the protein or ISF are believed to be important because of their effects on the content and intactness of certain bioactive protein subunits. Some studies have documented potential safety concerns on increased consumption of soy products. Impacts of soy products on thyroid and reproductive functions as well as on certain types of carcinogenesis require further study in this context. Overall, existing data are inconsistent or inadequate in supporting most of the suggested health benefits of consuming soy protein or ISF.
Collapse
Affiliation(s)
- Chao Wu Xiao
- Nutrition Research Division, Food Directorate, Health Products and Food Branch, Health Canada, 2203E Banting Research Centre, Ottawa, Canada.
| |
Collapse
|
121
|
Cope MB, Erdman JW, Allison DB. The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obes Rev 2008; 9:219-35. [PMID: 18419671 DOI: 10.1111/j.1467-789x.2007.00390.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Evidence concerning the relationship between soyfoods and weight loss was reviewed. Detailed searches of PubMed and Web of Science were performed to identify and evaluate evidence for or against four propositions related to soyfoods and weight loss (Data from in vitro, animal, epidemiologic, and clinical studies were evaluated and summarized). (1) Certain soyfoods will improve weight and/or fat loss when fed at isolcaloric levels (similar calories given across experimental conditions, but not necessarily at a level to maintain current body weight); generally supportive evidence in animal studies, but there is no compelling support in human studies. (2) Certain soyfoods will improve weight and fat loss when included as part of a diet by affecting caloric intake; limited supportive evidence in animal and human studies. (3) Certain soyfoods will prevent/improve risk factors related to glucoregulatory function and cardiovascular health during weight loss; some evidence supporting this proposition, but additional evidence is needed before conclusions can be made. (4) Certain soyfoods will minimize the loss of bone mass during weight loss; no data available pertinent to this proposition. Limitations in existing data make it difficult to reach conclusions regarding these four propositions. Overall, the current data suggest that soyfoods are as good as other protein sources for promoting weight loss and there is a suggestive body of evidence that soyfoods may confer additional benefits, but results must be carefully interpreted and additional evidence is needed before making firm conclusions concerning soyfoods and weight loss.
Collapse
Affiliation(s)
- M B Cope
- Department of Nutrition Sciences, University of Alabama at Birmingham School of Public Health, Birmingham, AL, USA
| | | | | |
Collapse
|
122
|
Vaughn N, Rizzo A, Doane D, Beverly JL, Gonzalez de Mejia E. Intracerebroventricular administration of soy protein hydrolysates reduces body weight without affecting food intake in rats. PLANT FOODS FOR HUMAN NUTRITION (DORDRECHT, NETHERLANDS) 2008; 63:41-46. [PMID: 18157697 DOI: 10.1007/s11130-007-0067-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/15/2007] [Accepted: 11/19/2007] [Indexed: 05/25/2023]
Abstract
Some studies suggest that increased consumption of soy protein hydrolysates may cause body weight loss but the mechanism of action is unknown. The objective of this investigation was to determine whether intracerebroventricular (i.c.v.) infusion of soy protein hydrolysates decrease food intake and body weight. Adult male Sprague Dawley rats (n = 24) received i.c.v. injections of soy hydrolysate I (SH I) or soy hydrolysate II (SH II) three times weekly for 2 weeks. Krebs solution and leptin were used as negative and positive controls respectively. SH I (6.5-20 kDa with a strong band at 14 kDa) was produced by hydrolysis with alcalase, and SH II (approximately 2 kDa) was obtained by hydrolysis and ultrafiltration. Leptin successfully reduced body weight (-1.60 g) 24 h (p = 0.0093) after the third injection. SH I caused significant (p = 0.0009) decreases in body weight (-1.70 g) 24 h after the third injection but not after 48 h. SH II showed a tendency to prevent body weight gain but this effect was short of statistical significance (p < 0.40). Food intake was not affected by any of the soy hydrolysate treatments but leptin injection did cause significant decreases in food intake (p < 0.05). Data suggest that soy alcalase hydrolysate can decrease, in the short term, the rate of body weight gain independently of food consumption. This preliminary data show that soy peptides may play a role on body weight regulation, possibly by increasing energy utilization.
Collapse
Affiliation(s)
- Nerissa Vaughn
- Department of Food Science & Human Nutrition, University of Illinois at Urbana-Champaign, 228 Edward Madigan Laboratory, 1201 West Gregory Drive, Urbana, IL 61801, USA
| | | | | | | | | |
Collapse
|
123
|
Molecular nutraceutics as a mean to investigate the positive effects of legume seed proteins on human health. Trends Food Sci Technol 2007. [DOI: 10.1016/j.tifs.2007.04.002] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
124
|
Adams MR, Anthony MS, Chen H, Clarkson TB. Replacement of dietary soy protein isolate with concentrates of soy 7S or 11S globulin has minimal or no effects on plasma lipoprotein profiles and biomarkers of coronary risk in monkeys. Atherosclerosis 2007; 196:76-80. [PMID: 17350024 PMCID: PMC2239216 DOI: 10.1016/j.atherosclerosis.2007.01.037] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/01/2006] [Revised: 01/09/2007] [Accepted: 01/29/2007] [Indexed: 11/18/2022]
Abstract
Effects of soy peptide fractions on risk factors for coronary heart disease are unknown. We compared the effects of a soy protein isolate, a soy 7S fraction concentrate and a soy 11S fraction concentrate on total plasma cholesterol, HDL cholesterol, LDL+VLDL cholesterol and triacylglycerol in adult male cynomolgus monkeys. Effects on biomarkers of coronary risk [soluble E-selectin, vascular cell-adhesion molecule-1 (VCAM-1), monocyte chemoattractant protein-1 (MCP-1), transforming growth factor beta-1 (TGF-beta-1) and plasminogen activator inhibitor-1 (PAI-1)] were also determined. Relative to a soy- and isoflavone-free diet (casein and lactalbumin as the source of protein), soy protein isolate had the predicted favorable effects on plasma lipoproteins, i.e., reductions in total and VLDL+LDL cholesterol (8 and 14%, respectively) (P's<0.05) and a 41% increase in HDL (P<0.05). Effects of 7S and 11S on these variables were less favorable. In fact, there was a 7% increase in total plasma cholesterol concentration (P<0.05) in monkeys fed 7S that was accounted for primarily by an increase in VLDL+LDL cholesterol. There was no effect of any protein source on cardiovascular biomarkers. Replacement of dietary soy protein isolate with concentrated 7S or 11S does not result in improvement of plasma lipoprotein profiles or cardiovascular biomarkers in monkeys.
Collapse
Affiliation(s)
- Michael R Adams
- Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
| | - Mary S Anthony
- Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - Haiying Chen
- Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - Thomas B Clarkson
- Department of Pathology/Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| |
Collapse
|
125
|
Xiao CW, Wood C, Huang W, L'Abbé MR, Gilani GS, Cooke GM, Curran I. Tissue-specific regulation of acetyl-CoA carboxylase gene expression by dietary soya protein isolate in rats. Br J Nutr 2007; 95:1048-54. [PMID: 16768825 DOI: 10.1079/bjn20061776] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
We have recently reported that intake of soya protein isolate (SPI) inhibited the DNA-binding activities of hepatic thyroid hormone receptor (TR). The genes for acetyl-CoA carboxylase (ACC), a rate-limiting enzyme in fatty acid synthesis, contain the thyroid hormone response element in their promoters and are regulated by TR. The present study has examined the effect oflong-term feeding of SPI and soya isoflavones (ISF) on the gene expression and protein phosphorylation of different ACC isoforms in different tissues and plasma triacylglycerol (TAG) levels in rats. Sprague-Dawley female rats were fed diets containing 20% casein or alcohol-washed SPI with or without supplemental ISF for 70, 190 and 310d. SPI intake significantly reduced plasma TAG concentrations compared with casein, whereas supplemental ISF had no effect. Hepatic ACCα and ACCβ mRNA abundance and protein content were markedly lowerin the rats fed SPI than in those fed casein. The protein contents of ACCα in the kidneyand ACCβ, the predominant isoform in the heart and kidney, were unchanged by dietary SPI.The ratios of phospho-ACCα/ACCα and phospho-ACCβ/ACCβ were not differentamong dietary groups in all tissues measured. The present study demonstrates that ingestion ofSPI decreases plasma TAG level and down-regulates ACCα and ACCβ gene expression in the liver but not in the heart and kidney. The results indicate that the effect of SPI is tissue-specific and that alteration of ACC gene expression rather than phosphorylation status may play a major role in the regulation of ACC activities by soya proteins.
Collapse
Affiliation(s)
- Chao Wu Xiao
- Nutrition Research Division, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, Ottawa, ON, Canada K1A 0L2.
| | | | | | | | | | | | | |
Collapse
|
126
|
Abstract
Soy protein is an important component of soybeans and provides an abundant source of dietary protein. Among the dietary proteins, soy protein is considered a complete protein in that it contains ample amounts of all the essential amino acids plus several other macronutrients with a nutritional value roughly equivalent to that of animal protein of high biological value. Soy protein is unique among the plant-based proteins because it is associated with isoflavones, a group of compounds with a variety of biological properties that may potentially benefit human health. An increasing body of literature suggests that soy protein and its isoflavones may have a beneficial role in obesity. Several nutritional intervention studies in animals and humans indicate that consumption of soy protein reduces body weight and fat mass in addition to lowering plasma cholesterol and triglycerides. In animal models of obesity, soy protein ingestion limits or reduces body fat accumulation and improves insulin resistance, the hallmark of human obesity. In obese humans, dietary soy protein also reduces body weight and body fat mass in addition to reducing plasma lipids. Several potential mechanisms whereby soy protein may improve insulin resistance and lower body fat and blood lipids are discussed and include a wide spectrum of biochemical and molecular activities that favorably affect fatty acid metabolism and cholesterol homeostasis. The biologic actions of certain constituents of soy protein, particularly conglycinin, soyasaponins, phospholipids, and isoflavones, that relate to obesity are also discussed. In addition, the potential of soy protein in causing food allergy in humans is briefly discussed.
Collapse
Affiliation(s)
- Manuel T Velasquez
- Department of Medicine, George Washington University Medical Center, Washington, DC, USA
| | | |
Collapse
|
127
|
Serum triacylglycerol-lowering effect of soybean β-conglycinin in mildly hypertriacylglycerolemic individuals. ACTA ACUST UNITED AC 2007. [DOI: 10.1016/j.eclnm.2006.12.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
128
|
Anderson JW, Fuller J, Patterson K, Blair R, Tabor A. Soy compared to casein meal replacement shakes with energy-restricted diets for obese women: randomized controlled trial. Metabolism 2007; 56:280-8. [PMID: 17224344 DOI: 10.1016/j.metabol.2006.10.013] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2006] [Accepted: 10/02/2006] [Indexed: 01/22/2023]
Abstract
Recent studies suggest that obese individuals lose weight more rapidly and lose more total weight with soy protein than with animal protein as a major diet component. The purpose of the present study was to evaluate the weight-loss efficacy and changes in body composition, waist circumference, blood pressure, and levels of plasma glucose, insulin, serum lipids, C-reactive protein, and homocysteine from consumption of either 3 soy shakes or 3 casein shakes daily as part of a 16-week, energy-restricted diet for obese women. Forty-three women with body mass index values of 30 to 40 kg/m(2) were randomized to intensive dietary interventions using either casein (n = 21) or soy (n = 22) shakes. Subjects were instructed to consume 3 shakes, 1 prepackaged entrée, and 5 servings of fruits or vegetables daily to achieve an energy intake of 4.5 to 5.0 MJ/d. Subjects attended classes weekly or biweekly. Weight, body fat, lipid, and glucose measurements were obtained at baseline and at 8 and 16 weeks. For both groups combined, subjects lost 8.1% of initial body weight (7.7 kg) at 8 weeks and 13.4% (12.7 kg) at 16 weeks. Weight loss from baseline did not differ significantly by group and, for completing subjects, was 14.0% +/- 1.2% (mean +/- SE) for casein and 12.8% +/- 1.4% for soy. With the intention-to-treat analysis, weight losses at 16 weeks were 12.5% +/- 1.4% for casein and 11.3% +/- 1.2% for soy. Body fat losses were 23.7% +/- 2.0% for casein and 21.8% +/- 2.4% for soy and did not differ significantly. Both study groups lost significant amounts of weight with a highly structured behavioral program incorporating 4 meal replacements and vegetables and fruits. Differences in weight loss and body composition changes between casein and soy treatments were not significant.
Collapse
Affiliation(s)
- James W Anderson
- Department of Internal Medicine, University of Kentucky, Lexington, KY 40504, USA.
| | | | | | | | | |
Collapse
|
129
|
YU L, SHIRAI N, SUZUKI H. Effects of Some Chinese Spices on Body Weights, Plasma Lipids, Lipid Peroxides, and Glucose, and Liver Lipids in Mice. FOOD SCIENCE AND TECHNOLOGY RESEARCH 2007. [DOI: 10.3136/fstr.13.155] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
130
|
Xiao CW, Mei J, Huang W, Wood C, L'abbé MR, Gilani GS, Cooke GM, Curran IH. Dietary soy protein isolate modifies hepatic retinoic acid receptor-beta proteins and inhibits their DNA binding activity in rats. J Nutr 2007; 137:1-6. [PMID: 17182792 DOI: 10.1093/jn/137.1.1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Retinoic acid receptors (RAR) belong to the same nuclear receptor superfamily as thyroid hormone receptors (TR) that were previously shown to be modulated by dietary soy protein isolate (SPI). This study has examined the effect of dietary SPI and isoflavones (ISF) on hepatic RAR gene expression and DNA binding activity. In Expt. 1, Sprague-Dawley rats were fed diets containing 20% casein or 20% alcohol-washed SPI in the absence or presence of increasing amounts of ISF (5-1250 mg/kg diet) for 70, 190, or 310 d. In Expt. 2, weanling Sprague-Dawley rats were fed diets containing 20% casein with or without supplemental ISF (50 mg/kg diet) or increasing amounts of alcohol-washed SPI (5, 10, and 20%) for 90 d. Intake of soy proteins significantly elevated hepatic RARbeta2 protein content dose-dependently compared with a casein diet, whereas supplemental ISF had no consistent effect. Neither RARbeta protein in the other tissues measured nor the other RAR (RARalpha and RARgamma) in the liver were affected by dietary SPI, indicating a tissue and isoform-specific effect of SPI. RARbeta2 mRNA abundances were not different between dietary groups except that its expression was markedly suppressed in male rats fed SPI for 310 d. DNA binding activity of nuclear RARbeta was significantly attenuated and the isoelectric points of RARbeta2 were shifted by dietary SPI. Overall, these results show for the first time, to our knowledge, that dietary soy proteins affect hepatic RARbeta2 protein content and RARbeta DNA binding activity, which may contribute to the suppression of retinoid-induced hypertriglyceridemia by SPI as reported.
Collapse
Affiliation(s)
- Chao Wu Xiao
- Nutrition Research Division, Food Directorate, Health Products and Food Branch, Health Canada, 2203C Banting Research Centre, Ottawa, ON, Canada K1A 0L2.
| | | | | | | | | | | | | | | |
Collapse
|
131
|
Kohno M, Hirotsuka M, Kito M, Matsuzawa Y. Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin. J Atheroscler Thromb 2006; 13:247-55. [PMID: 17146153 DOI: 10.5551/jat.13.247] [Citation(s) in RCA: 105] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Soy protein isolate (SPI) is known to reduce the risk of heart disease by lowering serum cholesterol and triacylglycerol (TG) levels. Soybean beta-conglycinin, which is a component of SPI, might be the active ingredient that prevents and/or ameliorates lifestyle-related diseases, such as hyperlipidemia and obesity. This study aimed to determine the efficacy of soybean beta-conglycinin for lowering the human serum TG level and visceral fat. Randomized double-blind placebo-controlled designs were used to test the effect of dietary beta-conglycinin, which was taken in the form of candy. [Test 1]In order to examine the serum TG level, 138 volunteers aged 26 to 69 years with TG concentrations above 1.69 mmol/L participated in the study. The subjects were divided at random into two different groups: the test group only consumed the experimental candy containing beta-conglycinin and the placebo group only consumed the placebo candy containing casein. The test period consisted of a 2-wk pre-evaluation phase to screen the participants, a 12-wk consumption period and a 4-wk post-evaluation phase. The serum TG concentrations were significantly reduced in the test group, compared with the placebo group, after consuming the experimental candy. [Test 2]In order to measure visceral fat by means of CT scanning, 102 volunteers aged 26 to 69 years with body mass indices (BMI) between 25 and 30 participated in the study. The subjects were divided at random into two different groups as for Test 1. The test period consisted of a 2-wk pre-evaluation phase to screen the participants, a 20-wk consumption period and a 4-wk post-evaluation phase. A significant reduction in visceral fat only occurred in the beta-conglycinin group. This study showed that beta-conglycinin is an effective food ingredient that will be of use to reduce high serum TG concentrations and to prevent obesity.
Collapse
Affiliation(s)
- Mitsutaka Kohno
- Food Science Research Institute, Fuji Oil Co. Ltd., Sumiyoshi, Izumisano, Osaka 598-8540, Japan.
| | | | | | | |
Collapse
|
132
|
Zaidi D, James KA, Wagner GF. Passive immunization of lactating mice with stanniocalcin-1 antiserum reduces mammary gland development, milk fat content, and postnatal pup growth. Am J Physiol Endocrinol Metab 2006; 291:E974-81. [PMID: 16772321 DOI: 10.1152/ajpendo.00601.2005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
During pregnancy and lactation in rodents, stanniocalcin-1 (STC-1) production by the ovaries is upregulated markedly and released into the circulation. The mammary glands are one target of this systemically delivered hormone. The purpose of this study was to lower serum levels of STC-1 in lactating mice through passive immunization so as to monitor the effects on mammary gland function and postnatal pup growth. Passive immunization significantly reduced circulating hormone levels, and pup growth was significantly compromised (30%), even though control and experimental litters had ingested equal amounts of milk. When mammary glands were analyzed, the alveolar area was significantly reduced in antibody-treated mothers. An analysis of milk composition revealed no changes in lactose, protein, or electrolyte levels but an approximately 40% reduction in triglyceride levels. The latter was due to a significant reduction in mammary gland lipoprotein lipase activity and led to a significant buildup of triglycerides in the serum. Body fat content was also significantly reduced in pups from antibody-treated mothers, whereas pup fecal fat content was increased. In mothers, passive immunization also caused significant behavioral effects, in particular, increased locomotor and hindleg rearing activities. Collectively, the results suggest that systemically derived STC-1 has important effects on mammary gland development and the transfer of serum-based triglycerides into milk. Locomotor effects suggest that STC-1 also has a role in maternal behavior.
Collapse
Affiliation(s)
- Deenaz Zaidi
- Department of Physiology and Pharmacology, Faculty of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada
| | | | | |
Collapse
|
133
|
Deak NA, Murphy PA, Johnson LA. Effects of NaCl Concentration on Salting-in and Dilution During Salting-out on Soy Protein Fractionation. J Food Sci 2006. [DOI: 10.1111/j.1750-3841.2006.00028.x] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
134
|
Wang W, de Mejia EG. A New Frontier in Soy Bioactive Peptides that May Prevent Age-related Chronic Diseases. Compr Rev Food Sci Food Saf 2005; 4:63-78. [DOI: 10.1111/j.1541-4337.2005.tb00075.x] [Citation(s) in RCA: 265] [Impact Index Per Article: 13.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
135
|
Kasai N, Ikehara H. Stepwise extraction of proteins and carbohydrates from soybean seed. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2005; 53:4245-52. [PMID: 15884867 DOI: 10.1021/jf048337y] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
The stepwise hot water extraction of soybeans, which were extractions in a series of procedures of whole soybean seeds, dehulled and sliced ones, and pressed ones carried out by autoclaving, was investigated to study the localization in the seed and their characteristics. The characteristics of each extraction were studied by HPLC, SDS-PAGE, components analysis, microscopic observation, and effect for some enzymes. Carbohydrates were easier to extract than protein. In the extractions, the ratio of uronic acid per total sugar was constantly about 0.3. A comparison of these extracts, soybean milk, extraction from defatted soybean meal, and soybean milk residues was also carried out, and the characteristics and the localization were investigated. Mid-sized proteins in soybean milk were easy to extract. However, hardly any high molecular weight proteins or high molecular weight carbohydrates were extracted. The proteins and carbohydrates were considered to be localized in the middle lamella and in the protein and/or oil bodies of the cell, and the proteins and carbohydrates were gradually extracted through seed and cell breaking. Gelation was observed only in the boiled extracts from whole seeds. Pepsin and trypsin digests of the high molecular weight protein had inhibitory activity against the angiotensin I converting enzyme.
Collapse
Affiliation(s)
- Naoya Kasai
- Laboratory of Food Chemistry, Division of Applied Biological Chemistry, Graduate School of Agriculture and Biological Sciences, Osaka Prefecture University, 1-1 Gakuen-cho, Sakai, Osaka 599-8531, Japan.
| | | |
Collapse
|